PHARMA-PACK (0426.468.517), Inactive: annual accounts and directors

PHARMA-PACK

KBO/BCE: BE 0426.468.517

Line	2022	2021	2020	2019	2018	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Balance sheet: assets
Total assets`20/58`	2.9m	2.2m	2.4m	2.0m	1.8m	1.7m	1.4m	1.4m	1.0m	925,893	954,993	987,782	1.1m	1.0m	701,196	661,698
Fixed assets`21/28`	47,718	412,468	449,203	494,038	541,391	436,734	481,835	488,815	438,230	444,506	455,762	475,228	513,061	531,189	87,913	102,910
Intangible fixed assets`21`	26,097	29,481	34,608	39,736	44,863	-	-	-	-	-	-	-	-	-	-	-
Tangible fixed assets`22/27`	19,617	380,982	412,590	452,298	494,524	434,729	479,831	486,810	436,226	442,502	453,758	473,223	511,057	529,185	85,909	100,905
Land and buildings`22`	-	313,720	324,760	335,800	346,840	360,640	371,680	382,720	393,760	404,800	415,840	426,880	437,920	448,960	71,951	79,146
Plant, machinery and equipment`23`	12,313	60,107	74,017	88,462	99,170	12,509	14,735	17,841	10,044	1,450	9,545	16,504	27,755	31,758	12,980	14,167
Furniture and vehicles`24`	7,304	7,155	13,813	28,036	48,514	61,581	93,417	86,250	32,422	36,252	28,372	29,840	45,382	48,467	977	7,592
Financial fixed assets`28`	2,004	2,004	2,004	2,004	2,004	2,004	2,004	2,004	2,004	2,004	2,004	2,004	2,004	2,004	2,004	2,004
Current assets`29/58`	2.9m	1.7m	1.9m	1.5m	1.3m	1.3m	919,757	921,411	603,847	481,387	499,232	512,554	572,480	503,155	613,283	558,789
Stocks and contracts in progress`3`	929,635	855,174	583,623	644,780	584,062	486,870	317,745	290,598	214,197	154,736	181,187	177,401	120,150	59,626	33,494	38,744
Stocks`30/36`	929,635	855,174	583,623	644,780	584,062	486,870	317,745	290,598	214,197	154,736	181,187	177,401	120,150	59,626	33,494	38,744
Amounts receivable within one year`40/41`	768,519	642,731	1.2m	754,325	613,714	660,772	496,136	530,359	340,723	285,827	272,144	292,795	390,947	301,251	404,905	415,500
Trade receivables`40`	709,807	576,526	1.2m	652,009	566,194	599,622	478,569	528,242	338,767	285,724	272,144	290,983	390,947	301,037	352,829	415,500
Other amounts receivable`41`	58,712	66,204	62,316	102,316	47,520	61,150	17,567	2,117	1,956	103	-	1,812	-	214	52,076	-
Cash at bank and in hand`54/58`	1.2m	248,162	98,816	88,996	85,792	117,453	105,876	100,454	48,927	40,824	45,798	42,255	61,322	142,278	174,885	104,073
Deferred charges and accrued income`490/1`	-	-	-	-	10,054	-	-	-	-	-	103	103	61	-	-	472
Balance sheet: equity and liabilities
Total equity and liabilities`10/49`	2.9m	2.2m	2.4m	2.0m	1.8m	1.7m	1.4m	1.4m	1.0m	925,893	954,993	987,782	1.1m	1.0m	701,196	661,698
Equity`10/15`	1.7m	1.1m	557,071	127,924	314,496	281,503	234,617	114,680	136,201	190,909	327,311	397,113	370,747	293,829	267,183	219,248
Contributions`10/11`	14,653	18,592	18,592	18,592	18,592	18,592	18,592	18,592	18,592	18,592	18,592	18,592	18,592	18,592	18,592	18,592
Issued capital`100`	-	-	18,592	18,592	18,592	18,592	18,592	18,592	18,592	18,592	18,592	18,592	18,592	18,592	18,592	18,592
Reserves`13`	1.7m	1.0m	538,479	109,332	295,904	262,911	216,025	96,088	117,609	172,317	308,719	378,521	352,154	275,237	248,591	200,656
Non-distributable reserves`130/1`	1,465	1,859	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Legal reserve`130`	-	-	1,859	1,859	1,859	1,859	1,859	1,859	1,859	1,859	1,859	1,859	1,859	1,859	1,859	1,859
Reserves not available under the articles`1311`	1,465	1,859	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Tax-exempt reserves`132`	5,517	7,000	7,000	7,000	7,000	7,000	7,000	7,000	7,000	7,000	7,000	7,000	7,000	7,000	7,000	7,000
Distributable reserves`133`	1.7m	1.0m	529,620	100,472	287,045	254,052	207,166	87,229	108,750	163,458	299,860	369,662	343,295	266,378	239,732	191,797
Amounts payable`17/49`	1.2m	1.1m	1.8m	1.9m	1.5m	1.4m	1.2m	1.3m	905,876	734,984	627,682	590,669	714,795	740,515	434,013	442,450
Amounts payable after more than one year`17`	-	127,895	145,121	206,864	209,105	191,778	244,366	206,257	227,467	197,946	205,238	212,896	238,020	263,453	34,132	48,527
Financial debts`170/4`	-	127,895	145,121	206,864	209,105	191,778	244,366	206,257	227,467	197,946	205,238	212,896	238,020	263,453	34,132	48,527
Amounts payable within one year`42/48`	1.2m	962,102	1.6m	1.6m	1.3m	1.2m	922,610	1.1m	678,409	536,202	409,899	377,773	476,775	477,062	399,881	375,321
Current portion of amounts payable after more than one year`42`	12,408	102,673	113,126	154,078	161,091	61,456	76,789	57,312	28,677	26,834	33,691	28,481	25,432	26,396	14,395	14,233
Financial debts`43`	-	315,000	388,999	387,999	288,678	238,900	176,000	172,000	-	-	-	-	3,361	3,419	2,763	3,318
Credit institutions`430/8`	-	315,000	388,999	387,999	288,678	238,900	176,000	172,000	-	-	-	-	3,361	3,419	2,763	3,318
Trade debts`44`	817,566	307,698	756,376	885,222	604,419	680,040	445,098	661,997	442,979	419,713	278,410	286,194	347,087	403,356	314,136	296,296
Suppliers`440/4`	817,566	307,698	756,376	885,222	604,419	680,040	445,098	661,997	442,979	419,713	278,410	286,194	347,087	403,356	314,136	296,296
Taxes, remuneration and social security`45`	355,808	224,329	375,190	205,496	256,451	239,585	200,568	173,824	168,636	64,497	75,358	41,956	79,685	23,023	43,528	61,474
Taxes`450/3`	249,735	106,720	246,214	47,704	39,310	52,011	110,360	105,176	98,681	20,095	20,010	16,529	50,877	1,416	27,619	37,349
Remuneration and social security`454/9`	106,073	117,609	128,975	157,793	217,141	187,574	90,208	68,648	69,954	44,401	55,347	25,428	28,808	21,607	15,910	24,124
Other amounts payable`47/48`	2,785	12,401	14,556	14,556	-	8,566	24,155	24,155	38,118	25,159	22,441	21,141	21,210	20,868	25,059	-
Accrued charges and deferred income`492/3`	-	-	-	-	775	-	-	-	-	836	12,545	-	-	-	-	18,603
Income statement
Non-recurring operating income`76A`	-	2,411	10,947	4,688	10,547	-	31,582	6,025	-	5,070	1,042	9,855	6,034	196,938	124	5,631
Gross operating margin`9900`	3.3m	1.9m	1.7m	1.0m	1.5m	1.0m	1.1m	905,848	759,945	535,068	425,169	363,274	428,577	44,478	287,885	229,426
Remuneration, social security and pensions`62`	1.9m	1.1m	1.1m	1.1m	1.3m	856,163	778,170	697,890	506,246	458,760	338,334	277,333	255,427	151,602	140,173	130,134
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets`630`	38,908	36,735	44,835	61,664	83,831	49,252	50,809	44,880	27,423	34,706	31,762	37,834	38,156	33,512	18,610	17,887
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)`631/4`	125,178	-	-	-	-	-	-	764	-	-	3,353	-	2,299	-	35,813	-
Other operating charges`640/8`	13,835	7,252	6,667	12,315	14,099	12,870	15,116	11,675	10,304	6,776	3,836	5,007	4,202	9,654	3,515	3,464
Non-recurring operating charges`66A`	-	-	-	-	-	-	-	333	-	1,396	6,843	-	-	-	-	-
Operating profit (loss)`9901`	1.2m	725,759	577,202	-168,886	82,896	99,828	222,059	150,638	215,971	34,827	47,884	43,100	128,493	-150,290	89,774	77,941
Financial income`75/76B`	53,219	9,560	25,292	6,817	21,171	6,653	6,359	532	3,321	1,857	1,863	5,211	3,068	3,736	441	445
Recurring financial income`75`	35,445	7,149	14,345	2,130	10,624	6,653	6,359	532	3,321	1,857	1,863	5,211	3,068	3,736	441	445
Non-recurring financial income`76B`	17,774	2,411	10,947	4,688	10,547	-	-	-	-	-	-	-	-	-	-	-
Financial charges`65/66B`	58,421	29,497	29,829	24,503	27,396	18,404	25,921	18,382	15,412	15,530	16,882	23,448	18,596	13,492	8,303	5,809
Recurring financial charges`65`	53,521	29,497	29,829	24,503	27,396	18,404	25,921	18,382	15,412	15,530	16,882	23,448	18,596	13,492	8,303	5,809
Non-recurring financial charges`66B`	4,900	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Profit (loss) for the period before taxes`9903`	1.2m	705,822	572,665	-186,572	76,670	88,077	234,079	138,479	203,880	24,828	27,065	34,717	118,999	36,892	82,036	78,209
Income taxes`67/77`	343,567	194,356	143,517	-	43,678	41,191	114,142	30,000	80,588	13,230	24,867	8,351	42,082	10,246	24,101	24,784
Profit (loss) for the period`9904`	899,793	511,466	429,148	-186,572	32,993	46,886	119,937	108,479	123,292	11,598	2,198	26,366	76,917	26,646	57,935	53,425
Profit (loss) for the period to be appropriated`9905`	899,793	511,466	429,148	-186,572	32,993	46,886	119,937	108,479	123,292	11,598	2,198	26,366	76,917	26,646	57,935	53,425
Appropriation of the result
Profit (loss) to be appropriated`9906`	899,793	511,466	429,148	-186,572	32,993	46,886	119,937	108,479	123,292	11,598	2,198	26,366	76,917	26,646	57,935	53,425
Transfer from equity`791/2`	-	-	-	186,572	-	-	-	21,521	54,708	136,402	72,000	-	-	-	-	-
Transfer to equity`691/2`	899,793	511,466	429,148	-	32,993	46,886	119,937	-	-	-	2,198	26,366	76,917	26,646	47,935	53,425
To other reserves`6921`	899,793	511,466	429,148	-	32,993	46,886	119,937	-	-	-	2,198	26,366	76,917	26,646	47,935	53,425
Profit to be distributed`694/7`	-	-	-	-	-	-	-	130,000	178,000	148,000	72,000	-	-	-	10,000	-
Return on contributions (dividend)`694`	-	-	-	-	-	-	-	130,000	178,000	148,000	72,000	-	-	-	-	-
Directors or managers`695`	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10,000	-
Social balance sheet
Average staff (FTE)`9087`	15	16.6	15.9	17.2	16	13.5	13.3	11.5	8.9	8.1	6.6	5.3	4.6	3.6	3.5	2.4
Hours worked`1013`	44,394	28,519	27,103	27,743	33,897	21,953	22,277	18,681	15,405	13,861	11,038	9,124	7,252	5,921	5,703	4,088
Document	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF

Financial year	Type	Filed	Reference	Document
31-12-2022	abbreviated format	12-07-2023	2023-00244915	PDF
31-03-2021	abbreviated format	03-11-2021	2021-76000480	PDF
31-03-2020	abbreviated format	24-11-2020	2020-71700296	PDF
31-03-2019	abbreviated format	31-10-2019	2019-72300503	PDF
31-03-2018	abbreviated format	31-10-2018	2018-71400504	PDF
31-12-2016	abbreviated format	17-07-2017	2017-32300484	PDF
31-12-2015	abbreviated format	18-08-2016	2016-43600039	PDF
31-12-2014	abbreviated format	31-08-2015	2015-54300301	PDF
31-12-2013	abbreviated format	24-07-2014	2014-33700582	PDF
31-12-2012	abbreviated format	28-08-2013	2013-49700108	PDF
31-12-2011	abbreviated format	30-08-2012	2012-50800229	PDF
31-12-2010	abbreviated format	23-06-2011	2011-20200261	PDF
31-12-2009	abbreviated format	29-06-2010	2010-23800526	PDF
31-12-2008	abbreviated format	28-07-2009	2009-49100259	PDF
31-12-2007	abbreviated format	29-08-2008	2008-69000010	PDF
31-12-2006	abbreviated format	27-06-2007	2007-30800153	PDF
31-12-2005	abbreviated format	13-07-2006	2006-47502751	PDF
31-12-2004	abbreviated format	08-08-2005	2005-63201282	PDF
31-12-2003	abbreviated format	20-07-2004	2004-48202482	PDF
31-12-2002	abbreviated format	30-07-2003	2003-55000294	PDF
31-12-2001	abbreviated format	22-07-2002	2002-40403538	PDF
31-12-2000	abbreviated format	04-07-2001	2001-33501612	PDF
31-12-1999	abbreviated format	30-06-2000	2000-34102143	PDF
31-12-1998	abbreviated format	05-07-1999	1999-30000135	PDF
31-12-1997	abbreviated format	24-06-1998	1998-21801938	PDF
31-12-1996	abbreviated format	30-05-1997	1997-10600590	PDF
31-12-1995	abbreviated format	08-07-1996	1996-32201833	PDF
31-12-1994	abbreviated format	30-06-1995	1995-33304660	PDF
31-12-1993	abbreviated format	23-06-1994	1994-19005298	PDF
31-12-1992	abbreviated format	10-06-1993	1993-12003868	PDF
31-12-1991	abbreviated format	17-06-1992	1992-11801519	PDF
31-12-1990	abbreviated format	29-05-1991	1991-06403646	PDF
31-12-1989	abbreviated format	29-06-1990	1990-13201339	PDF
31-12-1988	abbreviated format	15-06-1989	1989-08503357	PDF
31-12-1987	abbreviated format	07-06-1988	1988-06503943	PDF
31-12-1986	abbreviated format	19-06-1987	1987-10900349	PDF
31-12-1985	abbreviated format	05-06-1986	1986-11700055	PDF

Line	2022	2021	2020	2019	2018	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
EBITDA	1.3m	762,494	622,038	-107,222	166,726	149,080	272,868	195,518	243,395	69,533	79,647	80,934	166,649	-116,779	108,384	95,828
Cash flow	938,701	548,201	473,983	-124,908	116,823	96,139	170,746	153,360	150,715	46,304	33,961	64,200	115,074	60,158	76,545	71,312
Investment in fixed assets (approximation)	30,568	0	0	14,311	188,488	4,151	47,376	95,465	21,147	23,450	12,296	0	20,609	548,739	3,613	17,369
Change in cash	915,283	149,346	9,820	3,204	-	11,577	5,422	51,527	8,103	-4,975	3,544	-19,068	-80,956	-32,606	70,812	-
Working capital	1.7m	783,965	252,990	-159,251	-17,016	36,547	-2,853	-167,878	-74,562	-54,816	89,333	134,781	95,706	26,093	213,402	183,468
Solvency	59.1%	49.5%	23.7%	6.5%	17.1%	16.5%	16.7%	8.1%	13.1%	20.6%	34.3%	40.2%	34.2%	28.4%	38.1%	33.1%
Current ratio	2.41	1.81	1.15	0.90	0.99	1.03	1.00	0.85	0.89	0.90	1.22	1.36	1.20	1.05	1.53	1.49
Quick ratio	1.63	0.93	0.80	0.51	0.54	0.63	0.65	0.58	0.57	0.61	0.78	0.89	0.95	0.93	1.45	1.39
Debt to equity	0.69	1.02	3.22	14.49	4.83	5.05	4.97	11.30	6.65	3.85	1.92	1.49	1.93	2.52	1.62	2.02
ROE	52.3%	47.9%	77.0%	-145.8%	10.5%	16.7%	51.1%	94.6%	90.5%	6.1%	0.7%	6.6%	20.7%	9.1%	21.7%	24.4%
ROA	30.9%	23.7%	18.3%	-9.4%	1.8%	2.8%	8.6%	7.7%	11.8%	1.3%	0.2%	2.7%	7.1%	2.6%	8.3%	8.1%
Interest coverage	24.06	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Item	31-12-2022
Employees at the balance-sheet date	15
full-time	12
part-time	3
in full-time equivalents	14.1
Average over the year, in full-time equivalents	15.6
On a permanent contract	15
Joined	60
Left	65

Item	2022
Tangible fixed assets	€19,118
Intangible fixed assets	€11,450
Depreciation and write-downs of the year	€38,908

Overview

Lifetime

Key points

Result

Liquidity

Filings

Board and ownership

Recent changes

Official details

Annual accounts 2022

Insights on PHARMA-PACK

Financials

Annual accounts 2022

Balance sheet

Change in equityin €m

Change in cashin €m

Staff

Staff cost per FTE€125,322

Joined and left-5

Filed annual accounts

Filings

Key figures and ratios

Social balance sheet

Investments

Insights on PHARMA-PACK

Board & ownership

Last board

Mandates through the years

Control

Capital

Owners through the years

Articles of association

Capital transactions

Network & group

No group

Acquisitions and mergers

Connections & network

Timeline

Timeline

History

Company details

Purpose, financial year and meetings according to the articles of association

Name, seat, purpose and duration

General meeting and financial year

Absorbed by INFINITY PHARMA in August 2023